A more recent version of this regulatory record is available. This version is kept only as a historical record. Please see the Record history section for link to the most recent version.

dimoxystrobin (ISO); (2E)-2-{2-[(2,5-dimethylphenoxy)methyl]phenyl}-2-(methoxyimino)-N-methylacetamide; (E)-2-(methoxyimino)-N-methyl-2-[a-(2,5-xylyloxy)-o-tolyl]acetamide


List details

Basic info

Status Submitted
Submitter Hungary
Regulatory programme
  • PPP
CLP Annex VI Index Number
  • 616-164-00-7


Harmonised classification at the time of the proposal
  • Acute Tox. 4*, H332
  • Carc. 2, H351
  • Repr. 2, H361d***
  • Aquatic Acute 1, H400
  • Aquatic Chronic 1, H410
Proposed harmonised classification by the dossier submitter
  • Acute Tox. 4, H332
  • Carc. 2, H351
  • Lact., H362
  • Aquatic Acute 1, H400
  • Aquatic Acute 1, M-factor=100
  • Aquatic Chronic 1, H410
  • Aquatic Chronic 1, M-factor=100

Intention timeline

Date of intention 2016-11-04
Expected date of submission 2018-04-30
Submitted for accordance check 2018-05-31


Related substances

By adding any of the following substances to your watchlist, you would be monitoring this regulatory record and all possible new regulatory records related to that substance.

Related regulatory records

Record history

The following timeline shows when we detected changes of this regulatory record (the date might slightly differ from the date of the actual change). Additions between versions are hightlighted in green color, red color shows data removed between versions.

March 12, 2019
  • Proposed specific concentration limits by the dossier submitter: Inhalation: ATE=1.3 mg/L (dust and mist)
April 4, 2019
  • Regulatory programme: PPPActive substance in Plant Protection Products
May 14, 2019
  • Proposed harmonised classification by the dossier submitter: STOT RE 2, H373
This version
Feb. 18, 2019
  • Regulatory programme: Active substance in Plant Protection Products under the Annex I Renewal (AIR) process (Regulation (EC) No. 1141/2010 or Regulation (EC) No. 844/2012)PPP
  • Submitter email: clh.dossier@emmi.gov.hu
Add the related substance to your watchlist to monitor this regulatory record.